These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7851963)

  • 1. Macrophage priming and activation during fibrosarcoma growth: expression of c-myb, c-myc, c-fos, and c-fms.
    Alleva DG; Askew D; Burger CJ; Elgert KD
    Immunol Invest; 1994 Nov; 23(6-7):457-72. PubMed ID: 7851963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
    Alleva DG; Burger CJ; Elgert KD
    Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-induced modulation of macrophage class II MHC molecule mRNA expression.
    Askew D; Burger CJ; Elgert KD
    Mol Immunol; 1993 Jul; 30(10):911-20. PubMed ID: 8341283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosarcoma-induced increase in macrophage tumor necrosis factor alpha synthesis suppresses T cell responses.
    Alleva DG; Askew D; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 Aug; 54(2):152-60. PubMed ID: 8360594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages stimulated by receptor-ligand interactions exhibit differences in cell-cycle kinetics during tumor growth: stimulation at Mac-1 and Mac-3 receptors alters DNA synthesis.
    Walker TM; Yurochko AD; Burger CJ; Elgert KD
    Immunol Lett; 1992 Feb; 31(3):217-25. PubMed ID: 1548036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
    Alleva DG; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin and interferon-gamma differentially regulate the transcriptional levels of proto-oncogenes and cytokine genes during the differentiation of colony-stimulating factor type-1-derived macrophages.
    Myers MJ; Ghildyal N; Schook LB
    Immunology; 1995 Jun; 85(2):318-24. PubMed ID: 7642223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma.
    Alleva DG; Burger CJ; Elgert KD
    Scand J Immunol; 1994 Jan; 39(1):31-8. PubMed ID: 7904773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation.
    Alleva DG; Burger CJ; Elgert KD
    Immunobiology; 1993 Aug; 188(4-5):430-45. PubMed ID: 8244447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor growth and adherence change the expression of macrophage Mac-2.
    Askew D; Burger CJ; Elgert KD
    Cancer Lett; 1993 Apr; 69(1):67-74. PubMed ID: 8481895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal and tumor-bearing host macrophage responses: variability in accessory function, surface markers, and cell-cycle kinetics.
    Askew D; Yurochko AD; Burger CJ; Elgert KD
    Immunol Lett; 1990; 24(1):21-9. PubMed ID: 1695610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal and tumor-bearing host splenic macrophage responses to lipopolysaccharide.
    Yurochko AD; Askew D; Burger CJ; Elgert KD
    Immunol Invest; 1990 Feb; 19(1):41-55. PubMed ID: 1692569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages.
    Alleva DG; Walker TM; Elgert KD
    J Leukoc Biol; 1995 Jun; 57(6):919-28. PubMed ID: 7790775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
    Shipp MA; Reinherz EL
    J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.
    Yurochko AD; Burger CJ; Elgert KD
    Cell Immunol; 1990 Apr; 127(1):105-19. PubMed ID: 2138515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
    Liebermann DA; Hoffman-Liebermann B
    Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of monocytic differentiation and modulation of the expression of c-fos, c-fms and c-myc protooncogenes in human monoblasts by cytokines and phorbolester.
    Brach MA; Riedel D; Herrmann F
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(1):54-8. PubMed ID: 1696041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.
    Alleva DG; Elgert KD
    Immunobiology; 1995 Feb; 192(3-4):155-71. PubMed ID: 7782092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial dysregulation through interleukin-10.
    Walker TM; Burger CJ; Elgert KD
    Cell Immunol; 1994 Apr; 154(1):342-57. PubMed ID: 8131207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.